insights_auto
Why is GILD up 2.74%?
Dive Deeperchevron_right
GILD:BCBA
Gilead Sci Cedear
ARS 60,950.00
arrow_upward
+2.74%(+1,625.00) 1D
Oct 9, 5:00:00 PM GMT-3 · ARS
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GILD...
Open
ARS 59,400.00
High
ARS 61,050.00
Low
ARS 59,400.00
Mkt. cap
187.44B
Avg. vol.
0.00
Volume
455.00
52-wk high
ARS 61,700.00
52-wk low
ARS 41,160.00
Shares outstanding
1.24B
No. of employees
17K
Open
ARS 59,400.00
High
ARS 61,050.00
Low
ARS 59,400.00
Mkt. cap
187.44B
Avg. vol.
0.00
Volume
455.00
52-wk high
ARS 61,700.00
52-wk low
ARS 41,160.00
Shares outstanding
1.24B
No. of employees
17K
News stories
From web sources and news partners
AD HOC NEWS
·
7 hours ago
Gilead Sciences stock trades 0.17 percent above its Xetra close of EUR 134.84
Trefis
·
15 hours ago
Why Is Everyone Ignoring Gilead Stock’s High Cash Yield?
AD HOC NEWS
·
1 day ago
RBC raises target for Gilead Sciences stock to USD 126.00
Yahoo Finance
·
1 day ago
Therapeutics Stocks Q2 Highlights: Gilead Sciences (NASDAQ:GILD)
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sci Cedear
CEODaniel O'Day
Employees17K
FoundedJun 22, 1987
HeadquartersFoster City, California, United States
SectorBiotechnology
Websitegilead.com